UBS Maintains a 'Buy' on Thermo Fisher Scientific (TMO); Sequential Improvement, Solid Results
Tweet
Share
E-mailGet Alerts TMO Hot Sheet
Price: $589.04 --0%
Rating Summary:
34 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 5 | Down: 7 | New: 11
Rating Summary:
34 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 5 | Down: 7 | New: 11
Join SI Premium – FREE
UBS maintains a 'Buy' on Thermo Fisher Scientific (NYSE: TMO) price target raised from $60 to $62.
UBS analyst says, "Revenues of $3,133M (+15%) beat consensus & UBSe, as Q1 organic sales growth of 5% was above our 3% estimate. Operating margins were up 100 bps to 18.9% on pull-through on organic sales, productivity initiatives, & cost actions, and EPS of $1.18 beat UBSe/Street $1.15. Overall 4Q was solid, marked by modest qtr-over-qtr improvement in academic spending. With end-market trends appearing somewhat stable (for now) we believe valuation for TMO (11.5x ’12E EPS vs. ~15x for the group) continues to be compelling, and we remain Buy-rated on the shares."
"We project ‘12 sales of $12,262M (+4.6%; ~3% org, -3.5% F/X, +5.5% M&A) & EPS of $4.74 (was $4.76). We project ‘13 sales of $12,722M (+4%) & EPS of $5.29 (was $5.34)."
For an analyst ratings summary and ratings history on Thermo Fisher Scientific click here. For more ratings news on Thermo Fisher Scientific click here.
Shares of Thermo Fisher Scientific closed at $54.71 yesterday.
UBS analyst says, "Revenues of $3,133M (+15%) beat consensus & UBSe, as Q1 organic sales growth of 5% was above our 3% estimate. Operating margins were up 100 bps to 18.9% on pull-through on organic sales, productivity initiatives, & cost actions, and EPS of $1.18 beat UBSe/Street $1.15. Overall 4Q was solid, marked by modest qtr-over-qtr improvement in academic spending. With end-market trends appearing somewhat stable (for now) we believe valuation for TMO (11.5x ’12E EPS vs. ~15x for the group) continues to be compelling, and we remain Buy-rated on the shares."
"We project ‘12 sales of $12,262M (+4.6%; ~3% org, -3.5% F/X, +5.5% M&A) & EPS of $4.74 (was $4.76). We project ‘13 sales of $12,722M (+4%) & EPS of $5.29 (was $5.34)."
For an analyst ratings summary and ratings history on Thermo Fisher Scientific click here. For more ratings news on Thermo Fisher Scientific click here.
Shares of Thermo Fisher Scientific closed at $54.71 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Downgrades Core Natural Resources (CNR) to Neutral
- American Silver Corp. (USAS) PT Lowered to $9.25 at H.C. Wainwright
- BHP (BHP:LN) (BHP) PT Raised to GBP28.25 at Barclays
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
